Myocardial infarction (MI) initiates a cascade of biological changes ending in cardiac remodeling and heart failure. Recent studies have characterized transcriptional programs in post-infarct ...

The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

Obesity is a known cardiovascular risk factor, but the “obesity paradox” has been observed in patients with acute myocardial infarction (AMI), where obesity may be linked to better survival outcomes.